| Jeffrey S Hagan Od Pc | |
|
43271 Ford Rd, Canton, MI 48187-3340 | |
| (734) 981-8111 | |
| (734) 981-2327 |
| Full Name | Jeffrey S Hagan Od Pc |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 43271 Ford Rd, Canton, Michigan |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457406159 | NPI | - | NPPES |
| 5076656 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | (* (Not Available)) | Primary |
| Provider Name | Jeffrey S Hagan |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1124076104 PECOS PAC ID: 3870775547 Enrollment ID: I20110316001085 |
News Archive
Researchers at INSERM (France) have engineered a chimeric protein that increases cell survival, migration and proliferation to improve stem cell engraftment. The results, which appear in the September 2009 issue of Experimental Biology and Medicine, show that TAT-Tpr-Met, a cell permeable form of the hepatocyte growth factor receptor can increase the number of hepatic stem cells integrated into the liver of the mouse.
"Health programs integrating services for the prevention of mother-to-child transmission (PMTCT) of HIV into regular maternal, newborn and child health (MNCH) clinics, rather than operating PMTCT services as stand-along programs, are showing positive results in Kenya, experts say," PlusNews reports.
In news on the implementation of the health overhaul, administration officials seek to rebut Republican charges that the risk corridors will be a "bailout" for the insurance industry. Meanwhile, Gary Cohen, who helped oversee many of the rules for rolling out the law, is leaving the government.
CytRx Corporation (Nasdaq: CYTR), a biopharmaceutical research and development company specializing in oncology, today announced it has initiated a pivotal global Phase 3 clinical trial to evaluate the efficacy and safety of aldoxorubicin as a second-line treatment for patients with soft tissue sarcoma (STS) under a Special Protocol Assessment with the FDA.
The need to add tissue preserving therapies to the prostate cancer treatment continuum was highlighted prominently at the 108th Annual Meeting of the American Urological Association, in San Diego.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jeffrey S Hagan Od Pc 43271 Ford Rd, Canton, MI 48187-3340 Ph: (734) 981-8111 | Jeffrey S Hagan Od Pc 43271 Ford Rd, Canton, MI 48187-3340 Ph: (734) 981-8111 |
News Archive
Researchers at INSERM (France) have engineered a chimeric protein that increases cell survival, migration and proliferation to improve stem cell engraftment. The results, which appear in the September 2009 issue of Experimental Biology and Medicine, show that TAT-Tpr-Met, a cell permeable form of the hepatocyte growth factor receptor can increase the number of hepatic stem cells integrated into the liver of the mouse.
"Health programs integrating services for the prevention of mother-to-child transmission (PMTCT) of HIV into regular maternal, newborn and child health (MNCH) clinics, rather than operating PMTCT services as stand-along programs, are showing positive results in Kenya, experts say," PlusNews reports.
In news on the implementation of the health overhaul, administration officials seek to rebut Republican charges that the risk corridors will be a "bailout" for the insurance industry. Meanwhile, Gary Cohen, who helped oversee many of the rules for rolling out the law, is leaving the government.
CytRx Corporation (Nasdaq: CYTR), a biopharmaceutical research and development company specializing in oncology, today announced it has initiated a pivotal global Phase 3 clinical trial to evaluate the efficacy and safety of aldoxorubicin as a second-line treatment for patients with soft tissue sarcoma (STS) under a Special Protocol Assessment with the FDA.
The need to add tissue preserving therapies to the prostate cancer treatment continuum was highlighted prominently at the 108th Annual Meeting of the American Urological Association, in San Diego.
› Verified 6 days ago
Dr. Paul Allen Dearing, O.D. Optometrist Medicare: May Accept Medicare Assignments Practice Location: 1675 N Canton Center Rd, Canton, MI 48187 Phone: 734-844-0400 Fax: 734-844-0403 | |
Vision Without Limits Llc Optometrist Medicare: Medicare Enrolled Practice Location: 42461 Ford Rd, Canton, MI 48187 Phone: 734-981-5820 | |
Jeffrey Hagan, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 43271 Ford Rd, Canton, MI 48187 Phone: 734-981-8111 Fax: 734-981-2327 | |
Svs Vision Inc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 41793 Ford Rd, Canton, MI 48187 Phone: 734-233-6412 Fax: 734-518-1552 | |
Dr. Daniel John Trainor, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 44570 Ford Rd, Canton, MI 48187 Phone: 734-455-3190 | |
Elite Eyecare Centers Optometrist Medicare: Not Enrolled in Medicare Practice Location: 44750 Ford Rd, Canton, MI 48187 Phone: 734-455-3190 Fax: 734-455-1510 | |
Myeyedr. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1675 N Canton Center Rd, Canton, MI 48187 Phone: 734-844-0400 Fax: 734-844-0403 |